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Objectives: Factors related to readmission after pancreaticoduodenectomy (PD) may include postop-
erative morbidity and the functional status of the patient. This study aimed to retrospectively review our
institution's experience of readmission of patients who had undergone Whipple procedure PD.
Methods: Recidivism was defined as readmission to the primary or a secondary hospital within, respec-
tively, 30 days, 30–90 days or 90 days postoperatively. Associations between recidivism, perioperative
factors and patient characteristics were evaluated.
Results: During the past 5 years, 30-day, 30–90-day and 90-day recidivism rates were 14.5%, 18.5%
and 27.4%, respectively. The most common reasons for readmission included dehydration and/or
malnutrition (37.5% of readmissions) and pain (12.5%). Patients who underwent PD for chronic pancre-
atitis were more likely to be readmitted within 90 days of surgery than patients who underwent PD for
malignancy (P < 0.01). Intraoperative transfusion was also associated with 30–90-day and 90-day
recidivism (P < 0.01). Preoperative comorbidities, including Charlson Comorbidity Index score, number of
pre-discharge complications, type of Whipple reconstruction, preoperative biliary stenting, need for
vascular reconstruction and patient body mass index were not associated with recidivism.
Conclusions: Our data confirm previous reports indicating high rates of readmission after PD. To our
knowledge, this report is the first to demonstrate chronic pancreatitis as an independent risk factor for
readmission.
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Introduction
Traditionally, pancreaticoduodenectomy (PD) has been the most
common operation performed for head-predominant disease sec-
ondary to chronic pancreatitis. It is also the most common opera-
tion performed for pancreatic cancer. Advances in surgical
technique, anaesthesia and perioperative care during the last two
decades have significantly improved outcomes in patients under-
going this surgery.1–3 The recent implementation of clinical path-
ways for PD and regionalization of care to specialized centres for
the treatment of pancreatic cancer have led to decreases in post-
operative length of stay (LoS), mortality and the overall cost of
care.1,2,4
Although critical pathways have been successful in decreasing
LoS and hospital costs, as well as improving outcomes after
surgery, considerably high morbidity remains associated with PD.
Many centres have reported high rates of complications after
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Whipple procedure PD in the range of 30–60%.3,5 In addition to
the high rate of complications, PD is also associated with a sig-
nificant need for readmission after discharge. Previous studies
have reported rates of recidivism after PD in the range of
26–59%.6,7
This study attempts to determine recidivism rates subsequent
to PD at a high-volume centre, investigate risk factors and out-
comes associated with recidivism, and analyse the literature to
determine strong predictors for readmission after the Whipple
procedure.
Materials and methods
A retrospective review of patients undergoing PD at the University
of Cincinnati Medical Center between January 2005 and January
2010 was performed. Institutional review board (IRB) approval
was obtained prior to the initiation of this study and patients were
identified for inclusion using a University of Cincinnati pancreatic
surgery database. Our patient population includes all patients
who underwent PD performed by surgeons in the Division of
Surgical Oncology. Thus, surgeries performed by other surgeons
at our centre were excluded. These represent a small number of
cases that were not subject to the same, methodical pre- and
perioperative data collection.
Patient charts were reviewed to obtain data on a number of
factors, including: patient descriptors; patient past medical
history; perioperative factors, such as the placement of a stent;
Charlson Comorbidity Index (CCI) score; age-adjusted CCI score;
type of PD performed; transfusion requirements, and operative
time. Data on hospital LoS, morbidity and mortality were col-
lected for analysis. However, because an intent-to-treat analysis
was performed, patients who died were included in the study.
Recidivism was classified into three different categories to
examine the possibility that certain factors have a distinct effect on
the time course of recidivism. These categories were defined as
readmission to the primary or a secondary hospital within 30
days, within the 30–90-day period or within 90 days after surgery.
Groups are mutually exclusive within individual time periods
because a patient who was readmitted multiple times within a
time period was considered as one patient; however, if a patient
was readmitted more than once in different time periods, each
readmission was considered independently.
The CCI has been validated to predict the 1-year and 10-year
risk for death from comorbid disease in hospitalized patients. The
index takes into account a range of comorbid conditions such as
heart disease, AIDS and cancer (a total of 22 conditions), which
are assigned risk scores of 1, 2, 3 or 6. The scores are then summed
to a total score, which is used to predict mortality.8
Our definition of postoperative pancreatic fistula is based on
the International Study Group for Pancreatic Fistula (ISGPF) defi-
nition.9 A pancreatic fistula was defined as a drain output of any
measurable volume of fluid on or after postoperative day (PoD) 3
with an amylase content greater than three times the serum
amylase activity.9 Delayed gastric emptying was defined by the
ISGPF as the inability to return to a standard diet by the end of the
first postoperative week and included prolonged nasogastric intu-
bation of the patient.10
We followed a standard post-PD pathway for all patients. In
general, all patients received routine postoperative jejunostomies.
On PoD 3, the patient’s caloric goal was determined by a nutri-
tionist and the patient was started on an oral diet as well as tube
feeds. If a patient was able to meet his caloric goal through the oral
diet, he was weaned off tube feeds. However, if a patient was
unable to meet his goal through the oral diet, tube feeds were
cycled overnight until the patient achieved his caloric goals.
Pain management was initiated in all patients with an anaes-
thesia consultation on PoD 0. Pain wasmanaged using an epidural
catheter until PoD 5, when patients were started on both long-
and short-acting oral narcotics. Most patients with chronic pan-
creatitis arrived in hospital already on narcotics. These patients
were also discharged on a titrated dose of both long- and short-
acting oral narcotics, from which they were weaned over several
months.
sasVersion 8.1 (SAS Institute, Inc., Cary, NC, USA) was used to
perform the statistical analyses. Student’s t-test analysis was used
to determine significant differences among recidivism groups for
the following variables: patient age; body mass index (BMI); CCI
score; age-adjusted CCI score; length of procedure, and hospital
LoS. Chi-squared analyses were performed to determine signifi-
cant differences among recidivism groups for the remaining vari-
ables. A multiple logistic regression was used to further validate
variables that were statistically significant in the previous univari-
ate analyses. Results are expressed as mean standard error of the
mean.
Results
Patient demographics
Between January 2005 and January 2010, 124 patients underwent
PD. Their mean age was 61.7  1.3 years, mean BMI was 25.7 
0.4 and 52.4% of the group were men. Mean CCI score was 2.0
0.1. When this score was adjusted for age, it became 3.6  0.2. A
total of 16.9% of patients underwent PD for chronic pancreatitis
and 83.1% underwent PD for malignancy. A comparison of
patient demographics and presenting symptoms revealed that the
only statistically significant difference between patients who were
and were not readmitted was the diagnosis of chronic pancreatitis
(Table 1).
Perioperative characteristics
A total of 12.5% of patients with malignancy received preopera-
tive neoadjuvant therapy. The median duration of surgery was
406 min (range: 146–721 min). Median estimated blood loss was
500 ml (range: 100–5000 ml). Mean LoS was 10 days (range: 2–52
days). The minimum hospital LoS of 2 days reflected data for a
patient who died 2 days after the procedure. A total of 31 patients
required a blood transfusion during the operation (mean trans-
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fusion: 2.5 units; range: 1–25 units). Seventy-two (58.1%) patients
developed at least one complication within 30 days of PD.
Common complications included wound infection (19.9%),
intra-abdominal abscess (11.8%), delayed gastric emptying
(10.3%), pancreatic fistula (9.6%) and urinary tract infection
(8.8%).
Recidivism
Patients are described as those who were readmitted to hospital
within 30 days, within the 30–90-day period post-surgery, and
within 90 days of surgery. Of the 124 patients who underwent PD,
eight died or were lost from follow-up within 30 days of surgery
and an additional 14 died or were lost from follow-up by 90 days;
a total of eight patients died and 14 were lost from follow-up. The
30-day, 30–90-day and 90-day recidivism rates were 14.5%, 18.5%
and 27.4%, respectively. Dehydration and/or malnutrition repre-
sented a major cause of 30-day (33.3%), 30–90-day (39.1%) and
90-day (37.5%) recidivism. Pain was a causative factor in 16.7% of
readmissions within 30 days, 8.7% of readmissions within 30–90
days and 11.8% of readmissions within 90 days. Wound infection
was also a significant contributor to readmission, accounting for
11.1% of 30-day readmissions and 8.8% of all readmissions
within a 90-day period. Delayed gastric emptying accounted for
8.8% of all readmissions within 90 days. No patients were read-
mitted for pancreatic fistula.
Factors associated with recidivism
A univariate analysis was undertaken to assess for factors asso-
ciated with recidivism. No associations were found between
patient demographics (gender, age, BMI, CCI score, age-adjusted
CCI score) and readmission. There were also no associations
between readmission within 90 days and common comorbidities
(history of smoking, steroid use, chronic obstructive pulmonary
disease, heart disease, hypertension). Differences in perioperative
factors [preoperative biliary stenting, operation duration,
Whipple type (pylorus-preserving PD vs. standard PD)] were
also not associated with rates of readmission (Tables 2 and 3). By
univariate analysis, patients who underwent PD for chronic pan-
creatitis were more likely to be readmitted within 30 days and 90
days of surgery than patients who underwent surgery for malig-
nancy. The need for intraoperative transfusion was also associ-
ated with 30–90-day and 90-day recidivism (Tables 2 and 3).
Patients who required transfusion had a longer hospital LoS
(15.7  1.6 days vs. 12.0  0.7 days; P = 0.02) and more com-
plications (P = 0.04) than those who did not require intraopera-
tive transfusion. However, there was no significant increase in
hospital LoS (15.0  2.2 days vs. 12.7  0.7 days; P = 0.29) and
postoperative complications (P = 0.18) in patients requiring vein
resection compared with those who did not. Postoperative LoS
was also significantly associated with increased rates of readmis-
sion. The analysis showed that patients who were readmitted
within 30–90 days of discharge had a significantly increased LoS
(17.9  2.2 days vs. 11.8  0.6 days; P = 0.01) compared with
patients who did not require readmission within 30–90 days
(Table 3). All of these factors continued to be associated with
recidivism after multivariate analysis (Table 4).
Chronic pancreatitis vs. malignancy
Patients who underwent PD for chronic pancreatitis were younger
than those who underwent PD for cancer (51.1 2.5 years vs. 63.9
 1.2 years; P < 0.0001). The chronic pancreatitis group also
demonstrated fewer comorbidities than patients with malignancy,
as indicated by CCI scores (0.8 0.2 vs. 2.2 0.1; P < 0.0001) and
age-adjusted CCI scores (1.4  0.4 vs. 4.0  0.2; P < 0.0001).
Patients with chronic pancreatitis also had shorter operative time
(362  21 min vs. 421  10 min; P = 0.0156) and significantly
decreased estimated blood loss (391 44 ml vs. 705 78 ml; P =
0.0006) (Table 5). Overall, patients with malignancy were most
likely to be readmitted for malnutrition or dehydration (50.0%),
whereas the most common reason for readmission in patients
with chronic pancreatitis was inadequate pain control (35.7%)
(Table 6).
Table 1 Demographic data for the patients in this series (n = 124)
Readmitted
(n = 17)
Not
readmitted
(n = 107)
Gender, n (%)
Male 8 (47.1%) 58 (54.2%)
Female 9 (52.9%) 49 (45.8%)
Race, n (%)
African American 1 (5.9%) 8 (7.5%)
White 16 (94.1%) 89 (83.2%)
Asian American 0 (0%) 2 (1.9%)
Other 0 (0%) 8 (7.5%)
Smoking status, n (%)
Current 3 (17.6%) 26 (24.3%)
Prior 7 (41.2%) 26 (24.3%)
Never 7 (41.2%) 55 (51.4%)
COPD, n (%) 0 (0%) 10 (9.4%)
Diabetes, n (%) 4 (23.5%) 27 (25.2%)
Hypertension, n (%) 10 (58.8%) 43 (40.2%)
Heart disease, n (%) 2 (11.8%) 21 (19.6%)
Steroid use, n (%) 0 (0%) 4 (3.7%)
Chronic pancreatitis, n (%) 9 (52.9%)a 12 (11.2%)
Stent, n (%) 6 (35.3%) 45 (42.1%)
Transfusion, n (%) 4 (23.5%) 26 (24.3%)
Whipple type, n (%)
Pylorus-preserving PD 0 (0%) 2 (1.9%)
Standard PD 17 (100%) 105 (98.1%)
aP < 0.05.
COPD, chronic obstructive pulmonary disease; PD, pancreati-
coduodenectomy.
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Discussion
Pancreaticoduodenectomy is a complicated procedure that has
previously been associated with exceptionally high rates of mor-
bidity and mortality. Advances in patient care and the implemen-
tation of clinical pathways have decreased the mortality rate
associated with PD significantly and high-volume centres now
report rates of <5%.11–13 Although mortality rates have decreased
significantly, morbidity remains very high as a result of
Table 2 Univariate analysis of patients subject to recidivism
30-day recidivism 30–90-day recidivism 90-day recidivism
Gender, n (%)
Male 8/60 (13.3%) 14/53 (26.4%) 18/66 (27.3%)
Female 10/56 (17.9%) 9/49 (18.4%) 16/59 (27.1%)
Race, n (%)
African American 1/8 (12.5%) 2/7 (28.6%) 2/9 (22.2%)
White 17/100 (17.0%) 19/88 (21.6%) 30/106 (28.3%)
Asian American 0/2 (0%) 1/2 (50.0%) 1/2 (50.0%)
Other 0/6 (0%) 1/5 (20.0%) 1/8 (12.5%)
Smoking status, n (%)
Current 3/25 (12%) 5/23 (21.7%) 6/29 (20.7%)
Prior 6/29 (20.7%) 6/26 (23.1%) 9/32 (38.1%)
Never 9/59 (15.3%) 12/53 (22.6%) 19/64 (29.7%)
COPD, n (%) 0/9 (0%) 1/7 (14.3%) 1/10 (10.0%)
Diabetes, n (%) 4/28 (14.3%) 5/22 (21.6%) 8/31 (25.8%)
Hypertension, n (%) 10/48 (20.8%) 12/43 (27.9%) 19/53 (35.9%)
Heart disease, n (%) 2/20 (10.0%) 5/18 (27.8%) 6/23 (26.1%)
Steroid use, n (%) 0/4 (0%) 2/4 (50.0%) 2/4 (50.0%)
Chronic pancreatitis, n (%) 9/21 (42.9%)a 5/17 (29.4%) 10/21 (47.6%)a
Stent, n (%) 7/52 (13.5%) 10/44 (22.7%) 15/56 (26.8%)
Transfusion, n (%) 4/24 (16.7%) 13/23 (56.5%)a 14/30 (46.7%)a
Whipple type, n (%)
Pylorus-preserving PD 0/2 (0%) 0/2 (0%) 0/2 (0%)
Standard PD 18/114 (15.6%) 23/100 (23.0%) 34/122 (27.6%)
aP < 0.05.
Denominators differ in the three columns because each readmission was treated independently.
COPD, chronic obstructive pulmonary disease; PD, pancreaticoduodenectomy.
Table 3 Univariate analysis of data for patients subject to recidivism. Data are given as mean  standard error of the mean
30-day recidivism 30–90-day recidivism Any recidivism
Yes (n = 18) No (n = 98) Yes (n = 23) No (n = 79) Yes (n = 34) No (n = 90)
Age, years 61.9  4.0 61.2  1.2 62.1  3.0 60.5  1.4 61.8  2.6 61.7  1.2
BMI, kg/m2 25.7  1.1 25.6  0.5 25.2  1.0 25.8  0.6 25.8  0.9 25.6  0.5
CCI score 1.6  0.3 2.0  0.1 1.9  0.3 1.8  0.1 1.8  0.2 2.0  0.1
Age-adjusted CCI score 3.1  0.6 3.5  0.2 3.3  0.5 3.3  0.3 3.4  0.4 3.6  0.2
OR time, min 392.0  26.0 414.0  10.3 454.0  25.7 397.0  10.7 433.0  21.4 403.0  9.7
Initial LoS, days 11.0  1.0 13.5  0.8 17.9  2.2 11.8  0.6a 15.4  1.7 12.0  0.6
aP = 0.01.
BMI, body mass index; CCI, Charlson Comorbidity Index; OR, operating room; LoS, length of stay.
Table 4 Multivariate analysis
30-day
recidivism
30–90-day
recidivism
Any
recidivism
Chronic pancreatitis P = 0.0005 N/A P = 0.002
Length of stay N/A P = 0.02 N/A
Transfusion N/A P = 0.0006 P = 0.001
N/A, not applicable.
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postoperative complications such as sepsis, pancreatic fistula and
wound infection.5,14
In addition to the significant morbidity associated with this
procedure, there is also a high rate of readmission following PD.
The high rate of recidivism associated with PD is similar to rates
associated with other technically complex procedures. Whereas
this study found a 30-day readmission rate of 14.5%, research into
outcomes in other complicated procedures have identified 30-day
recidivism rates of 16.6% after gastrectomy, 16.7% after coronary
artery bypass and 18.4% after oesophagectomy.15 This study
aimed to assess the rate of recidivism, as well as factors associated
with an increased need for readmission in 124 patients who
underwent PD at a single high-volume centre. Even after region-
alization and the implementation of centres of excellence, 27.4%
of patients who underwent this intricate procedure required read-
mission within 90 days of discharge from hospital.
A review of the literature shows that many studies have assessed
mortality associated with PD. However, only a few have focused
on recidivism and only two have specifically addressed factors
associated with it (Table 7).6,7 Emick et al. in 2006 focused on the
factors associated with recidivism at a single high-volume institu-
tion.7 They found an overall recidivism rate at their institution of
26%. Factors associated with readmission included patient demo-
graphics (increased age and male gender), perioperative factors
(longer operative time, greater estimated blood loss, intraopera-
tive transfusion, vessel resection) and postoperative complications
(pancreatic fistula, wound infection, intra-abdominal abscess,
biliary leak, cholangitis, increased hospital LoS) (Table 7).7
The other major study to assess factors associated with recidi-
vism following PD was conducted by Yermilov et al.6 They under-
took a population-based method of appraisal to account for
readmission to the primary institution as well as to secondary
hospitals. This study found a recidivism rate of 59%, with 47% of
patients readmitted to secondary hospitals. Yermilov et al.
addressed factors associated with recidivism, as well as the most
common reasons for readmission.6 Patients who were readmitted
were more likely to have a high-grade malignancy (stage T4) or a
relatively long Los compared with patients who did not require
readmission within 1 year of PD (Table 7). The most common
reasons for readmission were progression of disease (24.3%),
surgery-related complications (14.0%), infections (12.3%) and
malnutrition (6.2%).6
Finally, a study by van Geenen et al. also examined reasons for
readmission after PD.16 It found a recidivism rate of 38.0%, with
the most common reasons for readmission consisting of progres-
sion of disease (64.0%), including biliary obstruction (14.2%) and
pain (19.8%), and surgery-related complications (44.0%), such as
abscess (10.4%), fistula (7.5%) and gastrointestinal obstruction
(7.5%) (Table 7).16
The recidivism rate identified in this study is similar to that
reported by Emick et al.,7 but lower than the 59% described by
Yermilov et al.6 The obvious explanation for this discrepancy may
refer to the inability of studies that focus on a single high-volume
institution to account for readmission to secondary institutions.
Yermilov et al. undertook a population-based study to capture all
admissions in primary and secondary hospitals.6 In our current
study, we attempted to capture all secondary hospital admissions
by reviewing notes from referring doctors. However, this method
probably underestimated the number of secondary hospital read-
missions. Therefore, our true recidivism rates may very well be
higher than the rates we report here. Another possible explanation
for the discrepancy in recidivism rates may refer to the fact that a
population-based study incorporates both low- and high-volume
institutions. Low-volume institutions are known to have poorer
outcomes compared with high-volume centres; thus the inclusion
of these centres in the study by Yermilov et al.16 may have contrib-
uted to the higher rate of readmission seen in their study.
Unlike Emick et al.,7 we did not find a significant association
between recidivism and patient demographics or most postopera-
tive factors such as abscess formation, wound infection and per-
cutaneous stents. In our institution we do not utilize postoperative
percutaneous stents and therefore did not experience any stent-
related episodes of cholangitis such as those documented in the
series reported by Emick et al.7 In addition, the average LoS for
patients who experienced complications was 16 days in our insti-
tution vs. 7 days for patients in the Hopkins series. Thus, it is
Table 5 Characteristics of patients operated for chronic pancreatitis
or malignancy
Chronic
pancreatitis
(n = 21)
Malignancy
(n = 103)
P-value
Age, years 51.1  2.5 63.9  1.2 <0.0001
Body mass index 26.4  1.4 25.5  0.5 NS
CCI score 0.8  0.2 2.2  0.1 <0.0001
Age-adjusted CCI score 1.4  0.4 4.0  0.2 <0.0001
EBL, ml 391.0  43.5 705.0  77.6 0.0006
OR time, min 362.0  21.0 421.0  10.0 0.0156
Length of stay, days 13.8  2.4 12.7  0.6 NS
CCI, Charlson Comorbidity Index; EBL, estimated blood loss; OR, oper-
ating room; NS, not significant.
Table 6 Reasons for recidivism in patients operated for chronic pan-
creatitis or malignancy
Chronic
pancreatitis
(n = 14)
Malignancy
(n = 26)
Malnutrition or dehydration 2/14 (14.3%) 13/26 (50.0%)
Pain 5/14 (35.7%) 0/26 (0%)
Wound infection 1/14 (7.1%) 2/26 (7.7%)
Othera 6/14 (42.9%) 11/26 (42.3%)
aOther reasons for readmission included (chronic pancreatitis, malig-
nancy): intra-abdominal abscess (0%, 7.7%); delayed gastric emptying
(14.3%, 0%); small bowel obstruction (0%, 7.7%); gastrointestinal bleed
(5.9%, 3.8%), and fever (0%, 7.7%).
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possible that some of our complications were recognized and
treated during initial hospitalization, thereby obviating the need
for subsequent readmission. The factors that appear to be the
most consistent predictors for readmission after PD in all studies
include postoperative hospital LoS and need for blood transfu-
sion. These most probably reflect the complexity of the operation
and subsequent postoperative care.
Our study did not find any correlation between patient demo-
graphics and preoperative factors and need for readmission. As
witnessed by their increased rates of complications and longer
LoS, patients who required intraoperative blood transfusion had
more complicated postoperative stays. These patients were also
significantly more likely to require readmission during the 30–90-
day period, as well as within 90 days of discharge. However, other
factors, such as vessel resection, which is also traditionally associ-
ated with more complicated procedures, were not associated with
increased complications, longer LoS or increased recidivism. The
only postoperative factor associated with increased recidivism was
hospital LoS. Furthermore, although LoS was associated with
increased complications, as well as an increased rate of recidivism,
there was no association between recidivism and postoperative
complications. The connection between an increased LoS and
recidivism was not related to the increased rate of complications
as patients with increased LoS were readmitted for malnutrition
and dehydration, rather than factors relating to postoperative
complications.
Major indications for PD include chronic pancreatitis and
malignancy. Patients who underwent PD for chronic pancreatitis
were younger and, as evidenced by their overall lower CCI score,
had less comorbidity at the time of operation than patients who
underwent PD for pancreatic cancer. These patients also had
shorter operations and significantly less blood loss. Yet, this
study found that patients who underwent PD for chronic pan-
creatitis were significantly more likely to require readmission
within 30 days and within 90 days of surgery compared with
patients who underwent PD for malignancy. To the best of
our knowledge, this is the first study to document this
correlation.
Not surprisingly, themost common reasons for the readmission
of chronic pancreatitis patients were inadequate pain control
(35.7%) and malnutrition (14.3%). Most postoperative care
pathways do not distinguish between patients with malignancy
and those with chronic pancreatitis. In general, patients with
chronic pancreatitis have a component of malnutrition and
exocrine insufficiency. Most, if not all, of these patients are also
narcotic-dependent. It is now our practice to impose a low
threshold for starting exocrine supplementation and enteral
nutrition, and for involving an anaesthesia pain specialist in the
postoperative setting.
Our finding of a higher frequency of readmission among
patients with chronic pancreatitis undergoing PD may be best
explained by differences in these patients’ access to care. Most
patients who undergo procedures for chronic pancreatitis have
chronic pain and restricted access to care. These patients fre-
quently have trouble maintaining employment, personal relation-
ships and even care with accessible community physicians. As a
result, postoperative symptoms are often evaluated only after
some delay and a resultant worsening of symptoms, and often in
an emergency room (ER) rather than in a clinic run by a primary
care doctor or a gastroenterologist. Additionally, higher tolerance
to pain medications may make these patients more difficult to
palliate in an outpatient or even an ER setting, leading to admis-
sions. By contrast, cancer patients typically require less postopera-
tive pain medication and have a better support system (including
family, friends and caregivers), which facilitates a more efficient
response to illness. Nonetheless, regardless of PD indication, our
data suggest that some patients, including those with chronic
pancreatitis, those with longer initial hospital LoS and those
Table 7 Factors associated with recidivism as identified in the literature
Study Cohort,
n
Recidivism Mortalitya Race Age CCI
score
Cancer
stage
OR
time
EBL Transfusion LoS Postoperative
complicationsb
Emick
et al.
(2006)7
1643 26% 22% White
P = 0.01
P < 0.001 – – P < 0.001 P = 0.02 P = 0.04 P = 0.02 P = 0.03
Yermilov
et al.
(2009)6
2023 59% 31% NS P < 0.003 P < 0.01 P < 0.003 – – – P < 0.01 –
Balcom
et al.
(2001)13
733 11% <2% – – – – – – – – –
van Geenan
et al.
(2001)16
283 38% – – – – – – – – – –
Sperti
et al.
(1994)17
31 11% – – – – – – – – – –
aMortality rate at 1 year post-surgery.
bPostoperative complications included pancreatic fistula (P = 0.0003), wound infection (P < 0.001), intra-abdominal abscess (P < 0.001), bile leak (P = 0.04) and cholangitis (P = 0.03).
CCI, Charlson Comorbidity Index; OR, operating room; EBL, estimated blood loss; LoS, length of stay; NS, not significant.
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requiring intraoperative transfusions, may benefit from expedited
postoperative follow-up care.
This retrospective review of our institution’s experience shows
an alarmingly high rate of recidivism, despite the many improve-
ments that have been made in the treatment of patients
requiring PD. Our study shows that patients with certain
risk factors, such as chronic pancreatitis, need for intra-
operative transfusion and increased hospital LoS, are more
likely to require readmission after discharge from hospital
and should be monitored more closely. Pain management and
malnutrition were two of the most common indicators for
readmission; these should be addressed in every patient before
discharge from hospital.
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